Background: Peyronie's disease (PD) is a relatively common clinical disorder of the penis that causes curvature and erectile dysfunction. However, the pathophysiological processes of PD are not well understood in current animal models and there exists limited clinical treatment options, which significantly impedes translational research.
Aim: This study aimed to develop a novel rat model of PD induced by local surgical tunica albuginea trauma and compare it with the TGF-β-induced model to elucidate the scientific soundness and feasibility of the local surgical tunica albuginea trauma-induced PD model.
Methods: A total of 24 male standard deviation rats were randomly allocated into three groups: sham group, surgical trauma group, and TGF-β group. The sham group received a skin incision only, whereas the surgical trauma group and the TGF-β group underwent PD model establishment via microsurgical tunica albuginea trauma and TGF-β injection, respectively. Six weeks post-modeling, penile blood perfusion, degree of curvature and erectile function were quantified. Penile tissues were subsequently harvested for histological analysis and Western blotting was used to evaluate tunica albuginea fibrosis.
Outcomes: PD model of surgical tunica albuginea trauma was successfully established and exhibited more pronounced fibrotic phenotypes in the penile tunica albuginea.
Results: Compared with TGF-β-induced models, laser speckle imaging revealed significantly reduced penile blood perfusion in surgical trauma group, accompanied by more severe penile curvature with corresponding angular and curvature alterations. HE and Masson's trichrome staining demonstrated marked local thickening and significantly increased collagen deposition in the penile tunica albuginea of rats in the surgical trauma group. Sirius red staining revealed a marked increase in collagen I and collagen III content. Immunofluorescence staining and Western blot analysis revealed that the surgical trauma group exhibited more pronounced alterations in the expression levels of fibrosis-related markers (Fibronectin, α-SMA, Collagen I, and Collagen III) in penile tissue.
Clinical implications: The rat model of tunica albuginea surgical trauma provides a promising option for preclinical PD research.
Strengths and limitations: The tunica albuginea surgical trauma-induced PD model established in our study has been scientifically validated. However, the precise pathogenesis of the model requires further investigation.
Conclusion: The tunica albuginea surgical trauma-induced PD model was successfully established and demonstrates a more pronounced fibrotic phenotype in the penile tunica albuginea, potentially better recapitulating the pathophysiological processes of PD.
Background: While the relationship between gut microbiota and erectile dysfunction (ED) has been reported, the specific pathways involved remain unclear.
Aim: This study aims to investigate the causal relationship between gut microbiota and ED, and to identify the potential role of plasma metabolites as mediators.
Methods: Utilizing aggregated genome-wide association study (GWAS) data, a comprehensive two-sample Mendelian randomization (MR) analysis was performed involving 196 gut microbiota taxa, 1400 plasma metabolites and ED. Causal relationships between gut microbiota, plasma metabolites and ED were explored. In addition, mediation analysis was applied to identify the pathway from gut microbiota to ED mediated by plasma metabolites.
Outcomes: This study reveals that plasma metabolites act as mediators regulating the influence of gut microbiota on ED.
Results: MR analysis identified causal relationships between six gut microbial taxa and ED, with Butyrivibrio increasing the risk of ED, while Alistipes, Prevotella 9, Dialister, Marvinbryantia, and LachnospiraceaeUCG010 exhibited protective effects. Additionally, 45 plasma metabolites demonstrated causal associations with ED. Finally, mediation analysis revealed four mediation relationships. Sensitivity analysis indicated no heterogeneity or pleiotropy in this study.
Clinical implications: Modulating gut microbiota or targeting specific metabolites may offer new therapeutic approaches for ED, highlighting the potential for microbiome-based interventions.
Strengths and limitations: The MR approach and large-scale GWAS data provide robust causal evidence, but the findings are limited by their focus on European populations and lack of experimental validation. Further studies are needed to confirm these mechanisms in diverse cohorts and functional models.
Conclusion: This study establishes a causal link between gut microbiota, plasma metabolites, and ED, identifying specific microbial taxa and metabolites as key contributors to ED risk. The mediating role of plasma metabolites highlights potential therapeutic strategies, such as probiotics or dietary interventions targeting harmful metabolites.
Background: Polydioxanone (PDO) thread is a synthetic absorbable surgical suture used for rejuvenation and lifting.
Aim: The aim of this study is to use PDO threads for rejuvenation and enlargement effect in patients with labium majus hypotrophy.
Methods: Twenty-one patients with labia majora hypotrophy were included in the study. Conventionally, surgery, fat filling or hyaluronic acid filling is used for labia majora rejuvenation. In this study, a different technique, the PDO thread suspension technique, was applied. For PDO thread, Hyundae Meditech Co.Ltd's Secret Line Up product containing 50 mm screw thread with 30 G-38 mm needle tip was used. It was planned to use 10 PDO threads for right and left labia majora. After a total of 20 needles were inserted, the needles were removed one by one and the PDO threads remained in the subcutaneous superficial layer and the procedure was terminated 5 min later. Preoperative and postoperative the Female Genital Self-Image Scale (FGSIS) scores of the patients were compared.
Outcomes: The overall FGSIS total score demonstrated a significant increase following the intervention.
Results: The FGSIS total mean score in the preoperative period was increased in the postoperative period. This difference was statistically significant. Moreover, the mean score calculated for each parameter of FGSIS in the preoperative period increased significantly in the postoperative period.
Clinical implications: These findings indicate a favorable safety profile for the use of PDO threads in this clinical context.
Strengths and limitations: The strength of the study is to introduce a minimally invasive and effective method for labia majora lifting, on the other hand, the small number of patients in the study, limitation of the study.
Conclusion: We would like to point out that in this study, we evaluated labium majus rejuvenation from the same perspective, based on the shaping and enlargement of genital appearance and its positive effect on self-confidence and increase in sexual functions. Unlike many labium majus rejuvenation procedures, this less invasive procedure has achieved similar results. In this context, it is a preferable alternative to surgery.
Introduction: Persistent genital arousal disorder/genitopelvic dysesthesia (PGAD/GPD) is associated with poor quality of life. Due to social stigma and its heterogeneous nature, many patients suffer without treatment.
Aims: This case presents the first example of the successful use of a glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist (GLP1/GIP RA) medication for the treatment of PGAD/GPD.
Methods: The patient was identified by the Sexual Medicine Research Team, retained as a patient at a sexual medicine clinic, and interviewed for the purposes of this case report.
Results: This case presents a 44-year-old woman with a lifelong history of PGAD/GPD symptoms that caused extreme distress and depression who experienced 95% resolution of her symptoms within 2 days of starting tirzepatide, a GLP1/GIPRA medication, for weight loss.
Conclusion: Increasing benefits of GLP1/GIPRAs are being uncovered, and further studies must investigate the potential for these medications to be used in patients with PGAD/GPD. This study also provides a potential mechanism for decreased arousal resulting from GLP1/GIP receptor activation in attention/reward pathways in the brain.
Background: During postmenopause, women frequently experience genitourinary symptoms that may result in sexual dysfunctions. Common treatments include hormone replacement therapy or vaginal lubricants. Pelvic floor muscle training (PFMT) has been observed to have beneficial effects on sexual function in other groups of women.
Aim: To evaluate the effect of PFMT on sexual function in postmenopausal women.
Methods: A systematic search was conducted in June 2025, in PubMed, Scopus, Web of Science, Medline, CINAHL databases, and the Google Scholar search engine. Inclusion criteria were randomized clinical trial articles published in English, in which at least one intervention addressed the study objective. A meta-analysis was conducted with a random-effects model.
Results: A total of five studies were selected after applying eligibility criteria. All included articles implemented PFMT interventions, showing improvements in sexual function as assessed by the Female Sexual Function Index. A significant positive effect was shown in the total score of Female Sexual Function Index in experimental group in comparison with control group (P < .001; standard mean difference [SMD] = 1.33; I 2 = 92%). A significant positive effect was also demonstrated in orgasm domain (P < .001; SMD = 1.91; I 2 = 97%), arousal domain (P < .001; SMD = 1.87; I 2 = 96%), and satisfaction domain (P < .001; SMD = 2.16; I 2 = 98%). A significant negative effect was found in desire domain (P < .001; SMD = 0.34; I 2 = 86%) and lubrication domain (P < .001; SMD = 0.26; I 2 = 87%) and finally no significant effects were found in pain domain.
Strengths and limitations: Although this is the first meta-analysis to address this topic in postmenopausal women, the results are heterogeneous and the scientific evidence remains limited.
Conclusion: PFMT appears to have positive effects on sexual function in postmenopausal women, particularly in aspects such as orgasm, arousal, and satisfaction.
Background: Premature ejaculation (PE) is a common male sexual dysfunction with treatment limitations including side effects and partner dependency.
Aim: To evaluate vacuum negative pressure hydropneumatic/pneumatic bubble massage (VNPHP/PBM) efficacy in primary PE (PPE) patients stratified by sexual frequency, focusing on subjective low-frequency (avoidance due to PE) vs objective low-frequency subgroups.
Methods: Retrospective analysis of 42 PPE patients: 22 low-frequency (LF; <4 intercourse/month) including 13 subjective (sub-LF) and 9 objective (ob-LF) vs 20 non-low-frequency (NLF; ≥4/month).
Outcomes: Primary: intravaginal ejaculation latency time (IELT); secondary: Premature Ejaculation Diagnostic Tool (PEDT), Self-Rating Anxiety Scale (SAS) scores, and sexual frequency changes at 4 weeks.
Results: Both groups showed significant improvements in IELT, PEDT, and SAS scores (P < .05). Low-frequency group showed greater improvements than NLF in PEDT reduction (6.36 ± 2.38 vs 7.90 ± 2.02, P = .03), SAS reduction (30.95 ± 9.57 vs 38.45 ± 8.85, P = .01), and sexual frequency increase (0.50 [0.00, 4.00] vs 1.00 [1.00, 2.00], P = .02). Crucially, sub-LF patients exhibited dramatic sexual frequency normalization (6.00 [4.00, 7.50] vs 2.00 [1.00, 2.00], P < .001), while ob-LF unchanged (P = .56). No adverse events.
Clinical implications: Vacuum negative pressure hydropneumatic/pneumatic bubble massage is a partner-independent therapy that not only improves ejaculatory control but also restores sexual activity in patients avoiding intercourse due to PE-related anxiety.
Strengths and limitations: Strengths: First study analyzing subjective vs objective low-frequency PE, standardized protocols. Limitations: Retrospective design, self-reported IELT data, lack of a control group, and the non-blinded nature of the study.
Conclusion: Vacuum negative pressure hydropneumatic/pneumatic bubble massage significantly improves PE symptoms with amplified benefits in low-frequency patients, particularly those with PE-driven sexual avoidance.
Background: Chronic stress can not only lead to depression-like behavior but also sexual dysfunction. Morinda officinalis oligosaccharides (MOO) is a formula of traditional Chinese medicine commonly used in invigorating the kidney and strengthening Yang, and relieving depression.
Aim: This study was designed to explore the effects and mechanisms of MOO in treating chronic stress-induced depression as well as sexual dysfunction.
Methods: The sucrose preference test, forced swimming test (FST) and novelty-suppressed feeding test (NSFT) were carried out to evaluate the depression status. Sexual behavior was tested on all mice, then the extent of damage to the testicles and epididymis was assessed by H&E staining; Serum sex hormone and neurotransmitters were assessed in the plasma by Enzyme-Linked Immunosorbent Assay. The testicular tissues were applied with the kit for the detection of antioxidant-related indexes and reproductive-related hormones.
Outcomes: The study evaluates the effects of MOO on depression-like behaviors and sexual function levels in CUMS-induced mice by analyzing the behavioral tests, histopathological staining of testis and epididymis, sex hormones, antioxidant capacity, neurotransmitter levels, and sexual behavior abilities of mice in each group.
Results: CUMS led to mice depression and plasma neurotransmitter levels decreased. Accompanying sexual dysfunction in depressed mice was also manifested in many aspects. Compared with the control group, the capture latency and mount latency of male mice in model group were significantly prolonged. HE showed that testicular and epididymal tissues of mice in the CUMS group were severely vacuolated. Testicular marker enzymes, antioxidant indexes and sex hormones were disorganized. The sperm concentration and viability in the epididymis of the mice in model group were significantly reduced. It was suggested that MOO could improve the damage caused by CUMS, and improve the sperm quality of the model mice.
Clinical translation: MOO are promising to be translated into a potential therapeutic drug for clinically improving chronic stress-related depression and sexual dysfunction.
Strengths and limitations: Multi-dimensional verification confirms that MOO can effectively alleviate depressive states and sexual dysfunction in CUMS-induced mice. Future studies should explore the in-depth mechanisms underlying its antidepressant and anti-sexual dysfunction effects based on relevant signaling pathways.
Conclusion: These results suggest that MOO can regulate sexual dysfunction and play a protective role in neurodevelopment during CUMS by regulating sex hormones.

